Revascularisation strategies in patients with significant left main coronary disease during the COVID ‐19 pandemic-Reference-Cited by-同舟云学术

Revascularisation strategies in patients with significant left main coronary disease during the COVID ‐19 pandemic

Published:2021-03-25 Issue:7 Volume:98 Page:1252-1261
ISSN:1522-1946
Container-title:Catheterization and Cardiovascular Interventions
language:en
Short-container-title:Catheter Cardiovasc Interv

Author:

Mohamed Mohamed O.¹²^ORCID,Curzen Nick³,Belder Mark⁴,Goodwin Andrew T.⁴⁵,Spratt James C⁶,Balacumaraswami Lognathen²,Deanfield John⁴,Martin Glen P.⁷,Rashid Muhammad¹²^ORCID,Shoaib Ahmad¹²^ORCID,Gale Chris P⁸⁹¹⁰,Kinnaird Tim¹¹,Mamas Mamas A.¹²

Affiliation:

1. Keele Cardiovascular Research Group, Centre for Prognosis Research Keele University Keele UK

2. Department of Cardiology Royal Stoke University Hospital Stoke‐on‐Trent UK

3. Wessex Cardiothoracic Unit Southampton University Hospital & Faculty of Medicine University of Southampton Southampton UK

4. National Institute for Cardiovascular Outcomes Research Barts Health NHS Trust London UK

5. Department of Cardiology James Cook University Hospital Middlesbrough UK

6. Department of Cardiology St George's University Hospital NHS Trust London UK

7. Division of Informatics, Imaging and Data Science, Faculty of Biology, Medicine and Health University of Manchester Manchester UK

8. Leeds Institute for Data analytics University of Leeds Leeds UK

9. Leeds Institute of Cardiovascular and Metabolic Medicine University of Leeds Leeds UK

10. Department of Cardiology Leeds Teaching Hospitals NHS Trust Leeds UK

11. Department of Cardiology University hospital of Wales Cardiff UK

Publisher

Wiley

Subject

Cardiology and Cardiovascular Medicine,Radiology, Nuclear Medicine and imaging,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ccd.29663

Reference32 articles.

1. 2018 ESC/EACTS Guidelines on myocardial revascularization

2. Percutaneous coronary angioplasty versus coronary artery bypass grafting in treatment of unprotected left main stenosis (NOBLE): a prospective, randomised, open-label, non-inferiority trial

3. Mortality after coronary artery bypass grafting versus percutaneous coronary intervention with stenting for coronary artery disease: a pooled analysis of individual patient data

4. New-generation stents compared with coronary bypass surgery for unprotected left main disease: A word of caution

5. Mortality after drug-eluting stents vs. coronary artery bypass grafting for left main coronary artery disease: a meta-analysis of randomized controlled trials

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cardiovascular Health Care Implications of the COVID-19 pandemic;Heart Failure Clinics;2023-04

2. Complex, high‐risk percutaneous coronary intervention types, trends, and in‐hospital outcomes among different age groups: An insight from a national registry;Catheterization and Cardiovascular Interventions;2022-09-02

3. Cardiovascular Health Care Implications of the COVID-19 pandemic;Cardiology Clinics;2022-08

4. Ethnicity in Complex High-Risk but Indicated Percutaneous Coronary Intervention Types and Outcomes;The American Journal of Cardiology;2022-07

5. Safety and efficacy of percutaneous coronary intervention versus coronary artery bypass graft in patients with STEMI and unprotected left main stem disease: A systematic review & meta-analysis;IJC Heart & Vasculature;2022-06